Status:

TERMINATED

Percutaneous Neuromodulation Therapy (PNT) With Chronic Low Back Pain Patients

Lead Sponsor:

RS Medical

Conditions:

Low Back Pain

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

The purpose of this study is to assess the benefits of Percutaneous Neuromodulation Therapy when compared to a reference sham treatment in the treatment of patients who have undergone surgical interve...

Eligibility Criteria

Inclusion

  • Low back pain for at least 6 months
  • If lower extremity pain present, must be present for at least 3 months
  • Visual analog scale (VAS) score for low back pain at least 50 out of 100
  • Lumbar or lumbosacral surgical intervention without pain relief
  • Central sensitization symptoms
  • Agrees to follow randomized treatment plan
  • 18 years of age or older
  • Signed informed consent form

Exclusion

  • Significant change to low back or lower extremity pain within 4 weeks prior to enrollment
  • Nociceptive and/or neuropathic pain symptoms in the spine due to structural and/or mechanical instabilities
  • Three or more lumbar or lumbosacral surgical interventions; one or more surgical interventions in areas other than lumbar or lumbosacral spine
  • Three or more lumbar vertebral segments fused
  • Lumbar or lumbosacral surgical intervention in last 9 months; areas other than lumbar or lumbosacral in last 12 months
  • Any additional surgical intervention required 3 months post-enrollment
  • Symptoms consistent with sympathetically-maintained pain
  • Evidence of serious neurological deficits or impairments
  • Significant changes in pain medications within 4 weeks prior to enrollment
  • Psychosocial issues that conflict with valid reporting by patient
  • Prior treatment with percutaneous electrical stimulation or sensitivity to electrical stimulation
  • Current use of another electrical stimulation device for low back or lower extremity pain
  • Current enrollment in another clinical trial within the last 30 days
  • Current or prior malignancy or cancer
  • Serious or uncontrolled systemic illness
  • Body mass index (BMI) greater than 40
  • Pregnant or intends to become pregnant during the study
  • Implanted medical device
  • Relationship with study staff
  • Unable to attend study office visits or complete study measures

Key Trial Info

Start Date :

December 1 2005

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 1 2008

Estimated Enrollment :

122 Patients enrolled

Trial Details

Trial ID

NCT00290238

Start Date

December 1 2005

End Date

September 1 2008

Last Update

June 1 2009

Active Locations (8)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (8 locations)

1

UCSD Pain Research Center

La Jolla, California, United States, 92037

2

Center for Prospective Outcome Studies

Atlanta, Georgia, United States, 03027

3

Mossberg Research Group

Eugene, Oregon, United States, 97401

4

Pain Specialists of Southern Oregon

Medford, Oregon, United States, 97504